Other

Preferred Stock, Shares Authorized

Polaryx Therapeutics, Inc. Preferred Stock, Shares Authorized remained flat by 0.0% to $40.00M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025

How to read this metric

An increase in authorized shares provides the company with greater flexibility to raise capital or issue stock-based compensation.

Detailed definition

This represents the maximum number of preferred stock shares that the company is legally permitted to issue under its co...

Peer comparison

Standard corporate governance disclosure; most companies maintain a large authorized buffer for flexibility.

Metric ID: other_preferred_stock_shares_authorized

Historical Data

2 periods
 Q4 '25Q1 '26
Value$40.00M$40.00M
QoQ Change+0.0%
Range$40.00M$40.00M

Frequently Asked Questions

What is Polaryx Therapeutics, Inc. 's preferred stock, shares authorized?
Polaryx Therapeutics, Inc. (PLYX) reported preferred stock, shares authorized of $40.00M in Q1 2026.
What does preferred stock, shares authorized mean?
The maximum number of preferred shares the company is allowed to create and sell.